 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Supportive Care - Neutropenia
| 251353 |
Growth B-T CXC chemokine |
GlaxoSmithKline |
I |
| AG)-1067 |
Anti-arrythmic |
Athero Genucs |
III |
| Avapro (CAIV-T Flumist) |
Vaccine |
Sanofi/Aventis Medimmune |
III |
| BNP7787 |
Chemoprotectant |
BioNumerik Pharmaceuticals |
III |
| Myeloid progenitor inhibitory factor-I |
Myeloid progentiry inhibitor factor |
Human Genome Sciences |
I |
| Prosaptide |
Analgesic |
Bio-Technology General |
II |
| Tedisamil |
Anti-arrythmic |
Solvay |
III |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
